文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

手术相关急性肾损伤的流行病学(EPIS-AKI):一项前瞻性国际观察性多中心临床研究

Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study.
PubMed 文献 · Intensive Care Med · 2023-07-28
一句话结论大型手术后约五分之一患者发生术后急性肾损伤(PO-AKI),其严重度与ICU及住院死亡率、住院时间进行性增加相关。

该国际前瞻性观察性多中心研究纳入30个国家、10568例接受大型手术(手术时长>2小时且术后入住ICU或高依赖病房)的患者,主要终点为术后72小时内按KDIGO标准定义的PO-AKI。1945例(18.4%)发生PO-AKI,其中KDIGO 1期1236例(63.5%)、2期500例(25.7%)、3期209例(10.7%);33.8%的PO-AKI为持续性,170/1945例(8.7%)在ICU接受肾脏替代治疗(RRT)。PO-AKI患者ICU死亡率6.3% vs 0.7%、住院死亡率8.6% vs 1.4%,ICU住院时间中位数3(Q1-Q3,1-6)天 vs 2(Q1-Q3,1-3)天、住院时间中位数14(Q1-Q3,9-24)天 vs 10(Q1-Q3,7-17)天均更长。危险因素包括高龄、高血压、糖尿病、慢性肾脏病、手术类型、时长及紧急程度、术中血管升压药和氨基糖苷类给药。

要点

  • 大型手术(>2小时且术后入ICU/高依赖病房)后72小时内PO-AKI发生率18.4%(1945/10568),KDIGO 1、2、3期分别占63.5%、25.7%、10.7%。
  • 33.8%的PO-AKI为持续性,8.7%(170/1945)的PO-AKI患者在ICU接受RRT。
  • PO-AKI患者ICU死亡率6.3% vs 无PO-AKI 0.7%,住院死亡率8.6% vs 1.4%,住院时间中位数14天 vs 10天。
  • 危险因素包括高龄、高血压、糖尿病、慢性肾脏病、手术类型、时长及紧急程度、术中血管升压药和氨基糖苷类给药。
  • PO-AKI严重度增加与不良结局进行性增加相关,作者认为PO-AKI是全球医疗的重要负担。

适用人群与场景

  • 30个国家接受大型手术(手术时长>2小时且术后入住ICU或高依赖病房)的患者。

诊断标准与关键阈值

  • PO-AKI定义为术后72小时内符合KDIGO标准的急性肾损伤。

研究设计与关键结果

  • 研究类型:国际前瞻性观察性多中心临床研究,纳入30个国家10568例大型手术患者。
  • 主要终点:术后72小时内PO-AKI发生1945例(18.4%),其中KDIGO 1期1236例(63.5%)、2期500例(25.7%)、3期209例(10.7%)。
  • PO-AKI持续性占33.8%;170/1945例(8.7%)PO-AKI患者在ICU接受RRT。
  • PO-AKI患者ICU死亡率6.3% vs 无PO-AKI 0.7%,住院死亡率8.6% vs 1.4%。
  • PO-AKI患者ICU住院时间中位数3(Q1-Q3,1-6)天 vs 无PO-AKI 2(Q1-Q3,1-3)天,住院时间中位数14(Q1-Q3,9-24)天 vs 10(Q1-Q3,7-17)天。
  • PO-AKI危险因素包括高龄、高血压、糖尿病、慢性肾脏病、手术类型、时长及紧急程度、术中血管升压药和氨基糖苷类给药。

证据类型、等级与局限

  • 证据类型:国际前瞻性观察性多中心临床研究。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为PO-AKI代表全球医疗的重要负担;对大型手术(>2小时且术后入ICU/高依赖病房)患者,术后72小时内应按KDIGO标准监测PO-AKI,并关注高龄、高血压、糖尿病、慢性肾脏病、手术类型、时长及紧急程度、术中血管升压药和氨基糖苷类给药等危险因素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: The incidence, patient features, risk factors and outcomes of surgery-associated postoperative acute kidney injury (PO-AKI) across different countries and health care systems is unclear.

METHODS: We conducted an international prospective, observational, multi-center study in 30 countries in patients undergoing major surgery (> 2-h duration and postoperative intensive care unit (ICU) or high dependency unit admission). The primary endpoint was the occurrence of PO-AKI within 72 h of surgery defined by the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. Secondary endpoints included PO-AKI severity and duration, use of renal replacement therapy (RRT), mortality, and ICU and hospital length of stay.

RESULTS: We studied 10,568 patients and 1945 (18.4%) developed PO-AKI (1236 (63.5%) KDIGO stage 1500 (25.7%) KDIGO stage 2209 (10.7%) KDIGO stage 3). In 33.8% PO-AKI was persistent, and 170/1945 (8.7%) of patients with PO-AKI received RRT in the ICU. Patients with PO-AKI had greater ICU (6.3% vs. 0.7%) and hospital (8.6% vs. 1.4%) mortality, and longer ICU (median 2 (Q1-Q3, 1-3) days vs. 3 (Q1-Q3, 1-6) days) and hospital length of stay (median 14 (Q1-Q3, 9-24) days vs. 10 (Q1-Q3, 7-17) days). Risk factors for PO-AKI included older age, comorbidities (hypertension, diabetes, chronic kidney disease), type, duration and urgency of surgery as well as intraoperative vasopressors, and aminoglycosides administration.

CONCLUSION: In a comprehensive multinational study, approximately one in five patients develop PO-AKI after major surgery. Increasing severity of PO-AKI is associated with a progressive increase in adverse outcomes. Our findings indicate that PO-AKI represents a significant burden for health care worldwide.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Zarbock A, Weiss R, Albert F, et al. Epidemiology of surgery associated acute kidney injury (EPIS-AKI): a prospective international observational multi-center clinical study. Intensive Care Med. 2023. PMID: 37505258. doi:10.1007/s00134-023-07169-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。